Rabbit Recombinant Monoclonal ECT2 antibody. Carrier free. Suitable for WB and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
WB | IP | ICC/IF | Flow Cyt (Intra) | IHC-P | |
---|---|---|---|---|---|
Human | Tested | Not recommended | Not recommended | Not recommended | Not recommended |
Mouse | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Rat | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Guanine nucleotide exchange factor (GEF) that catalyzes the exchange of GDP for GTP. Promotes guanine nucleotide exchange on the Rho family members of small GTPases, like RHOA, RHOC, RAC1 and CDC42. Required for signal transduction pathways involved in the regulation of cytokinesis. Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Regulates the translocation of RHOA from the central spindle to the equatorial region. Plays a role in the control of mitotic spindle assembly; regulates the activation of CDC42 in metaphase for the process of spindle fibers attachment to kinetochores before chromosome congression. Involved in the regulation of epithelial cell polarity; participates in the formation of epithelial tight junctions in a polarity complex PARD3-PARD6-protein kinase PRKCQ-dependent manner. Plays a role in the regulation of neurite outgrowth. Inhibits phenobarbital (PB)-induced NR1I3 nuclear translocation. Stimulates the activity of RAC1 through its association with the oncogenic PARD6A-PRKCI complex in cancer cells, thereby acting to coordinately drive tumor cell proliferation and invasion. Also stimulates genotoxic stress-induced RHOB activity in breast cancer cells leading to their cell death.
Protein ECT2, Epithelial cell-transforming sequence 2 oncogene, ECT2
Rabbit Recombinant Monoclonal ECT2 antibody. Carrier free. Suitable for WB and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
ab317826 is the carrier-free version of Anti-ECT2 antibody [EPR29014-24] ab317825.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
ECT2 also known as epithelial cell transforming sequence 2 is a guanine nucleotide exchange factor. It has a molecular mass of about 103 kDa. ECT2 is mostly expressed in proliferating cells including tumor cells and plays a role in cell cycle regulation. In its mechanical function ECT2 activates Rho family GTPases especially RhoA by facilitating the exchange of GDP for GTP. This activation is important for the regulation of cytoskeletal dynamics and cell division.
The regulation of cytoskeletal rearrangement and cell cycle progression involves ECT2. It is an essential part of the mitotic spindle assembly complex. ECT2 interacts with several cellular components to coordinate proper cytokinesis. This activity ensures that the cells divide correctly maintaining proper cell number and tissue homeostasis. ECT2's interaction with other proteins also determines its role in controlling cell shape and movement contributing further to cell cycle events.
ECT2 importantly participates in the RhoA signaling pathway which regulates the actin cytoskeleton. The proper function of this pathway is essential for cytokinesis and cell migration. ECT2's activity intersects with proteins like ROCK1 and ROCK2 which act downstream of RhoA to influence cell structure and integrity. In addition to RhoA signaling ECT2 is also involved in the Hippo pathway contributing to cell proliferation controls and tissue growth.
Scientists have found ECT2's involvement in cancer specifically in glioblastoma and breast cancer. Its overexpression in tumors correlates with increased cell proliferation and metastatic potential. In cancer progression ECT2 works with proteins like RhoA and YAP1 in Hippo signaling to influence cell growth and survival making it a target of interest in cancer research and therapeutic development. The aberrant regulation of ECT2 and its pathway partners can lead to uncontrolled cell division and tumor growth.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-ECT2 antibody [EPR29014-24] ab317825, the same antibody clone in a different buffer formulation.
Low expression: NIH:OVCAR-3 (PMID: 24386507), U-937.
The identity of the lower MW band at approximately 40 kDa is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-ECT2 antibody [EPR29014-24] (Anti-ECT2 antibody [EPR29014-24] ab317825) at 1/1000 dilution
Lane 1: LoVo (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg with NFDM/TBST
Lane 2: HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg with NFDM/TBST
Lane 3: NIH:OVCAR-3 (human ovary adenocarcinoma epithelial cell) whole cell lysate at 20 µg with NFDM/TBST
Lane 4: U-937 (human histiocytic lymphoma monocyte) whole cell lysate at 20 µg with NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 103 kDa, 36 kDa
Exposure time: 125s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com